CD274 and neoplasm: Targeting LAIR-1 through the inhibitory protein tyrosine phosphatase SHP-1 signaling could sensitize tumors resistant to PD-1/PD-L1 axis blockade which leads to the reduction of tumor growth and metastasis in the mouse model (5).